HighTower Advisors, LLC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 113 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$2,0000.0%15,0890.0%0.00%
Q3 2022$2,000
-50.0%
15,089
+0.0%
0.00%
Q2 2022$4,000
-50.0%
15,084
-5.6%
0.00%
Q1 2022$8,000
-11.1%
15,9770.0%0.00%
Q4 2021$9,000
-43.8%
15,977
+1.9%
0.00%
Q3 2021$16,000
-44.8%
15,677
-0.9%
0.00%
Q2 2021$29,000
-6.5%
15,8190.0%0.00%
Q1 2021$31,000
+47.6%
15,819
+0.3%
0.00%
Q4 2020$21,00015,7690.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$6,307,0004.30%
ETF MANAGERS GROUP, LLC 8,103,641$10,130,0000.22%
AdvisorShares Investments LLC 271,873$340,0000.08%
Platform Technology Partners 60,000$75,0000.04%
PINNACLE ASSOCIATES LTD 942,079$1,178,0000.02%
HRT FINANCIAL LP 883,510$1,104,0000.02%
Virtu Financial LLC 153,908$192,0000.02%
Tekla Capital Management LLC 413,481$517,0000.02%
Aries Wealth Management 23,400$33,0000.02%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 56,932$71,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders